Goldstone Psychiatry & Neuromodulation Center

Neuromodulation & Interventional Psychiatry

Neuromodulation Interventional Psychiatry 1

Advanced Treatment for When Standard Care Hasn't Been Enough—Coming Soon

A different kind of treatment, for a different kind of problem.

Some depression, anxiety and other conditions doesn’t respond to medication and therapy alone. For those situations, neuromodulation and interventional psychiatry offer something fundamentally different — treatments that work on the brain’s circuits directly.

Goldstone Psychiatry & Neuromodulation Center is preparing to bring these advanced options to our patients. The full suite — TMS therapy, Spravato (esketamine), and ketamine therapy — will launch in the months ahead.

Coming Soon

These services are not yet active at Goldstone, but they’re on the way. If you’d like to be notified when each treatment becomes available — or to begin your evaluation now and have advanced options ready as soon as they launch — please reach out.

What's coming

TMS Therapy.  FDA-cleared, non-invasive magnetic stimulation that targets the brain regions involved in depression. No medication, no anesthesia, no recovery time — patients stay awake and drive themselves home.

Accelerated TMS Protocols.  Compressed treatment schedules — including the FDA-cleared SWIFT protocol (a full course in six days) and emerging one-day options — for patients who can’t commit to several weeks of daily visits.

Spravato (Esketamine).  FDA-approved nasal spray for treatment-resistant depression. Delivered under clinical monitoring in our office, working through brain pathways that traditional antidepressants don’t touch.

Ketamine Therapy.  A different mechanism for severe or treatment-resistant depression. Carefully screened, monitored, and integrated into a broader plan.

Why we're building this

Standard psychiatry helps most people, but not everyone. For patients who’ve tried multiple medications, attended therapy, made lifestyle changes, and still feel stuck — there should be a next step that isn’t just “try another medication.”

We’re building a neuromodulation program that combines clinical sophistication with the warmth and continuity that Goldstone is known for. These treatments work best when they’re part of a coordinated plan — not delivered in isolation.

Begin your care now

You don’t need to wait for our advanced services to launch to start. A psychiatric evaluation or treatment-resistant depression consultation today gives us time to:

  • Get clear on your diagnosis and history
  • Optimize your current treatment plan
  • Identify whether you’d be a candidate for advanced options
  • Have your plan ready to go the moment those services come online

Common questions

When will TMS, Spravato, and ketamine be available at Goldstone?

We’re targeting a phased launch in the coming months. The fastest way to know when each service goes live is to be on our notification list — ask us at your visit, or reach out through Send Query.

No. Most patients benefit from beginning standard care now — careful diagnosis, medication optimization, and therapy planning. By the time advanced treatments are available, you’ll have a strong foundation in place and a clinician who already knows your story.

Most commercial plans and Medicare cover standard TMS and Spravato for treatment-resistant depression when criteria are met. Accelerated TMS and ketamine therapy are typically self-pay. We’ll verify benefits and provide a written estimate before any treatment begins.

Get on the waitlist for TMS, Spravato, and ketamine therapy at Goldstone — or book an evaluation now so your plan is ready when these services launch.